Adjuvant chemotherapy followed by conformal chemoradiotherapy in gastric carcinoma;Chimiothérapie adjuvante suivie d'une chimioradiothérapie conformationnelle dans les cancers de l'estomac

Cancer/Radiotherapie

Volumn 12, Issue 8, 2008, Pages 775-780

  Bouchbika, Z ^a   Quero, L ^a   Kouto, H ^a   Hennequin Baruch, V ^a   Gornet, J M ^a   Munoz, N ^a   Cojean Zelek, I ^b   Houdart, R ^b   Panis, Y ^c   Valleur, P ^d   Sergent, G ^a   Maylin, C ^a   Hennequin, C ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b Hôpital de la Croix Saint Simon   (France)

^c BEAUJON HOSPITAL   (France)

^d HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Chemotherapy; Conformal chemoradiotherapy; Gastric carcinoma

Indexed keywords

CISPLATIN; FLUOROURACIL; FOLINIC ACID;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; DIARRHEA; ESOPHAGITIS; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; HUMAN TISSUE; LUNG EMBOLISM; MALE; NAUSEA; NEUTROPENIA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; STOMACH CARCINOMA; SURVIVAL TIME; VOMITING;

ADULT; AGED; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; GASTRECTOMY; HUMANS; MIDDLE AGED; PROSPECTIVE STUDIES; RADIOTHERAPY, CONFORMAL; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 57249107882     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canrad.2008.04.006     Document Type: Article

References (17)

1. Bajetta E., Buzzoni R., Mariani L., Beretta E., Bozzetti F., Bordogna G., et al. Adjuvant chemotherapy in gastric cancer: 5-year results of a randomised study by the Italian Trials in Medical Oncology (ITMO) group. Ann Oncol 13 (2002) 299-307
2. Bonenkamp J.J., Hermans J., Sasako M., van de Velde C.J.H., Welvaart K., Songun I., et al. Extended lymph-node dissection for gastric cancer. N Engl J Med 340 (1999) 908-914
3. Bouche O., Raoul J.L., Bonnetain F., Giovannini M., Etienne P.L., Lledo G., et al. Randomized multicenter phase II trial of a biweekly regimen of fluorouracil and leucovorin (LV5FU2), LV5FU2 plus cisplatin, or LV5FU2 plus irinotecan in patients with previously untreated metastatic gastric cancer: a Fédération Francophone de Cancérologie Digestive group Study-FFCD 9803. J Clin Oncol 22 (2004) 4319-4328
4. Cunningham D., Allum W.H., Stenning S.P., Thompson J.N., Van de Velde C.J., Nicolson M., et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355 (2006) 11-20
5. Cuschieri A., Weeden S., Fielding J., Bancewicz J., Craven J., Joypaul V., et al. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Cooperative Group. Br J Cancer 79 (1999) 1522-1530
6. De Vita F., Orditura M., Matano E., Bianco R., Carlomagno C., Infusino S., et al. A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients. Br J Cancer 92 (2005) 1644-1649
7. Ducreux M., Nordlinger B., Ychou M., Milan C., Bouché O., Ducerf C., et al. Resected gastric adenocarcinoma: randomised trial of adjuvant chemotherapy with 5-FU-Cisplatin. Final results of the FFCD 8801 trial. Proc Am Soc Clin Oncol 19 (2000) 241
8. Earle C.C., and Maroun J.A. Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: revisiting a meta-analysis of randomised trials. Eur J Cancer 35 (1999) 1059-1064
9. GLOBOCAN. Cancer Incidence, Mortality and Prevalence Worldwide. Lyon: IARC Press; 2001.
10. Gunderson L.L., and Sosin H. Adenocarcinoma of the stomach: areas of failure in a re-operation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapy. Int J Radiat Oncol Biol Phys 8 (1982) 1-11
11. Hermans J., Bonenkamp J.J., Boon M.C., Bunt A.M., Ohyama S., Sasako M., et al. Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials. J Clin Oncol 11 (1993) 1441-1447
12. Janunger K.G., Hafstrom L., Nygren P., and Glimelius B. A systematic overview of chemotherapy effects in gastric cancer. Acta Oncol 40 (2001) 309-326
13. Kajitani T. Japanese Research Society for the study of gastric cancer. The general rules for gastric cancer study in surgery and pathology. Jpn J Surg 11 (1981) 127-145
14. Landry J., Tepper J., Wood W., Moulton E., Koener F., and Sullinger J. Patterns of failure following curative resection of gastric carcinoma. Int J Radiat Oncol Biol Phys 19 (1990) 1357-1362
15. Macdonald J.S., Smalley S.R., Benedetti J., Hundahl S.A., Estes N.C., Stemmermann G.N., et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345 (2001) 725-730
16. Mari E., Floriani I., Tinazzi A., Buda A., Belfiglio M., Valentini M., et al. Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis of published randomised trials. A study of the GISCAD (Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente). Ann Oncol 11 (2000) 837-843
17. Tepper J.E., and Gunderson L.L. Radiation treatment parameters in the adjuvant postoperative therapy of gastric cancer. Semin Radiat Oncol 12 (2002) 187-195